About NUVISAN
NUVISAN is a company based in Neu Ulm (Germany) founded in 1979. The company has 1,011 employees as of December 31, 2021. NUVISAN has completed 1 acquisition, including Inamed CRO. NUVISAN offers products and services including Discovery Services, Preclinical Services, Clinical Services, and CMC Services. NUVISAN operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Neu Ulm, Germany
- Employees 1011 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
$3.48 K (USD)0as on Dec 31, 2020
-
EBITDA
Not available
-
Latest Funding Round
$9.6 M (USD), Grant
Sep 20, 2022
-
Investors
ALS Global
& 2 more
-
Employee Count
1011
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NUVISAN
NUVISAN offers a comprehensive portfolio of products and services, including Discovery Services, Preclinical Services, Clinical Services, and CMC Services.
Supports target identification and validation in pharmaceuticals.
Conducts safety and efficacy testing for drug candidates.
Manages phase 1 and 2 trials for therapeutic advancement.
Handles drug substance and product development processes.
People of NUVISAN
Unlock access to complete
Funding Insights of NUVISAN
Investors in NUVISAN
NUVISAN has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include ALS Global, Gates Foundation and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Analytical testing and certification services are provided globally.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for NUVISAN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NUVISAN
NUVISAN has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Inamed CRO.
Investment portfolio details for NUVISAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRO services for respiratory drug development are specialized in.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for NUVISAN
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NUVISAN
Detailed financials for NUVISAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuvisan Comparisons
Peer comparison for NUVISAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NUVISAN
NUVISAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Detailed competitors of NUVISAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuvisan
Complete news archive for NUVISAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NUVISAN
NUVISAN was founded in 1979 and raised its 1st funding round 42 years after it was founded.
NUVISAN is headquartered in Neu Ulm, Germany. It is registered at Neu Ulm, Bavaria, Germany.
As of Dec 31, 2021, the latest employee count at NUVISAN is 1,011.
NUVISAN was founded in 1979 and is headquartered in Neu Ulm, Germany. Operations focus on the pharmaceutical and biotechnology sectors, where clinical trial supply chain management and bioanalytical testing services are delivered. These include logistics for investigational medicinal products, sample analysis, and regulatory compliance support. Services are extended to clients across Europe and beyond, ensuring efficient trial execution and data integrity.
NUVISAN's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
NUVISAN offers Discovery Services, Preclinical Services, Clinical Services, and CMC Services.
NUVISAN has made 1 acquisition, including Inamed CRO.
NUVISAN has 3 investors. Key investors include ALS Global, Gates Foundation, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.